Olverembatinib (HQP1351)-based therapy in adults with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia in blast phase: results from a real-world study
一项真实世界研究的结果显示,以奥维瑞巴替尼(HQP1351)为基础的疗法能够有效治疗复发或难治性费城染色体阳性急性淋巴细胞白血病或慢性粒细胞白血病急变期成人患者。
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1546371
Wen, Ziyu; Liu, Zhi; Ye, Xu; Fan, Zhiping; Lin, Ren; Huang, Fen; Xuan, Li; Li, Xiaofang; Jin, Hua; Dai, Min; Sun, Jing; Zhou, Xuan; Wang, Qiang; Liu, Xiaoli; Liu, Qifa; Zhou, Hongsheng; Xu, Na